Mode of Action of Ponazuril Against Toxoplasma gondii Tachyzoites in Cell Culture

Journal of Eukaryotic Microbiology

Volumn 50, Issue SUPPL., 2003, Pages 689-690

  Mitchell, Sheila M ^a   Zajac, Anne M ^a   Davis, Wendell L ^b   Lindsay, David S ^a  

^a CENTER FOR MOLECULAR MEDICINE AND INFECTIOUS DISEASES   (United States)

^b BAYER CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPROTOZOAL AGENT; PONAZURIL; TRIAZINE DERIVATIVE;

PARASITE;

ANIMAL; CELL LINE; CERCOPITHECUS; CONFERENCE PAPER; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; KIDNEY; TOXOPLASMA; ULTRASTRUCTURE;

ANIMALS; ANTIPROTOZOAL AGENTS; CELL LINE; CERCOPITHECUS AETHIOPS; KIDNEY; TOXOPLASMA; TRIAZINES;

ANIMALIA; CERCOPITHECUS; CERCOPITHECUS AETHIOPS; EQUIDAE; TOXOPLASMA GONDII;

EID: 0346336062     PISSN: 10665234     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1550-7408.2003.tb00689.x     Document Type: Conference Paper

References (13)

1. Buzby, J.C., & Roberts, T. 1996. ERS updates US foodborne disease costs for seven pathogens. Food Rev., 19:20-25.
2. Dubey, J.P., Lindsay, D.S., & Speer, C.A. 1998. Structure of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites, and biology and development of tissue cysts. Clin. Microbiol. Rev., 11:267-299.
3. Franklin, R.P., MacKay, R.J., Gillis, K.D., Tanhauser, S.M., Ginn, P.E., & Kennedy, T.J. 2003. Effect of a single dose of ponazuril on neural infection and clinical disease in Sarcocystis neurona-challenged interferon-gamma knockout mice. Vet. Parasitol., 114:123-130.
4. Gottstein, B., Eperon, S., Dai W.J., Cannas, A., Hemphill, A., & Greif, G. 2001. Efficacy of toltrazuril and ponazuril against experimental Neospora caninum infection in mice. Parasitol. Res., 87:43-48.
5. Hackstein, J.H., Mackenstedt, U., Mehlhorn, H., Meijerink, J.P., Schubert, H., & Leunissen, J.A. 1995. Parasitic apicomplexans harbor a chlorophyll a-D1 complex, the potential target for therapeutic triazines. Parasitol. Res., 81:207-216.
6. Jones, J.L., Lopez, A., Wilson, M., Schulkin, J., & Gibbs, R. 2001. Congenital toxoplasmosis: a review. Obst. Gynecol. Sur., 56:296-305.
7. Jones, D., Kruszon-Moran, ?? Wilson, M., McQuillan, G., Navin, T., & McAuley, J.B. 2001. Toxoplasma gondii infection in the United States: Seroprevalence and risk factors. Am. J. Epidemiol., 154:357-365.
8. Lindsay, D.S., Dubey, J.P., & Kennedy, T.J. 2000. Determination of the activity of ponazuril against Sarcocystis neurona in cell cultures. Vet Parasitol., 92:165-169.
9. Lindsay, D.S., Dubey, J.P., Toivio-Kinnucan, M.A. & Blagburn, B.L. 1995. Ultrastructural effects of diclazuril against Toxoplasma gondii and investigation of a diclazuril-resistant mutant. J. Parasitol., 81:459-466.
10. Luft, B.J., & Chua, A. 2000. Central nervous system toxoplasmosis in HIV. Pathogenesis, diagnosis, and therapy. Cur. Infect. Dis. Rep., 2:358-362.
11. Mead, P.S., Slutsker, L., Dietz, V., Caig, L.F., Bresee, J.S., Shapiro, C., Griffin, P.M., & Tauxe, R.V. 1999. Food-related illness and death in the United States. Emerg. Infect. Dis., 5:607-624.
12. Roberts T. & Frenkel, J.K. 1990. Estimating income losses and other preventable costs caused by congenital toxoplasmosis in people in the United States. J. Am. Vet. Med. Assoc., 196:249-256.
13. Soave, R. 2001. Prophylaxis strategies for solid-organ transplantation. Clin. Infect. Dis., 33:S26-S31.